ArticleCureus2025
Clinicopathologic Features and Management of Incidentally Detected Sub-centimeter Rectal Neuroendocrine Tumors: A Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rectal neuroendocrine tumors (NETs) are rare but increasingly recognized due to widespread colonoscopy screening for colorectal cancer and other gastrointestinal conditions. Advances in endoscopic technology have led to earlier and more frequent detection of small, often asymptomatic rectal lesions. While rectal NETs generally exhibit an indolent course, accurate histologic grading and staging, including assessment of depth of invasion and lymphovascular or perineural invasion, remain critical for risk stratification and treatment selection. There is limited real-world data on incidentally detected (<1 cm) rectal NETs across mixed clinical indications. We retrospectively analyzed the clinicopathologic characteristics and management of three patients diagnosed with small (<1 cm), grade 1 (G1) rectal NETs that were incidentally detected during endoscopic evaluations for various indications, including gastroesophageal reflux disease workup, ulcerative colitis surveillance, and routine colon cancer screening. All cases were reported using a standardized pathology protocol for colorectal NETs that included documentation of tumor size, depth of invasion, margin status, and lymphovascular invasion. All three patients exhibited well-differentiated G1 rectal NETs with Ki-67 ≤3% and minimal mitotic activity, confined to the submucosa and without lymphovascular or perineural invasion. Endoscopic resection was performed in all cases, with no complications or residual disease noted, and clinical follow-up ranging from 6 to 18 months showed no recurrences or disease progression. This case series highlights the importance of vigilant endoscopic recognition, standardized histopathological reporting, and risk-based management in identifying small rectal NETs at an early, highly manageable stage. Our findings align with current guideline-based recommendations that support conservative management with endoscopic resection and surveillance for most subcentimeter, well-differentiated rectal NETs, and add to the limited real-world evidence on incidentally detected lesions across diverse clinical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.